169 related articles for article (PubMed ID: 33044231)
21. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
22. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
23. Immune Priming of the Tumor Microenvironment by Radiation.
Jiang W; Chan CK; Weissman IL; Kim BYS; Hahn SM
Trends Cancer; 2016 Nov; 2(11):638-645. PubMed ID: 28741502
[TBL] [Abstract][Full Text] [Related]
24. Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma.
Nieder C; Adam M; Astner ST
Anticancer Res; 2008; 28(2B):1325-7. PubMed ID: 18505073
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
[TBL] [Abstract][Full Text] [Related]
26. Brain metastases of malignant melanoma in Chinese: report of 23 cases.
Wang YC; Lee ST
Chin Med J (Engl); 2007 Jun; 120(12):1058-62. PubMed ID: 17637222
[TBL] [Abstract][Full Text] [Related]
27. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
Grimaldi AM; Simeone E; Giannarelli D; Muto P; Falivene S; Borzillo V; Giugliano FM; Sandomenico F; Petrillo A; Curvietto M; Esposito A; Paone M; Palla M; Palmieri G; Caracò C; Ciliberto G; Mozzillo N; Ascierto PA
Oncoimmunology; 2014; 3():e28780. PubMed ID: 25083318
[TBL] [Abstract][Full Text] [Related]
28. Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
Lee JH; Chen HY; Hsu FM; Chen JS; Liao WY; Shih JY; Yu CJ; Chen KY; Tsai TH; Yang JC
Oncologist; 2019 Dec; 24(12):e1417-e1425. PubMed ID: 31127020
[TBL] [Abstract][Full Text] [Related]
29. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
Barth RF; Yang W; Bartus RT; Rotaru JH; Ferketich AK; Moeschberger ML; Nawrocky MM; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):858-68. PubMed ID: 11849812
[TBL] [Abstract][Full Text] [Related]
30. Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma.
Brenneman RJ; Sharifai N; Fischer-Valuck B; Hassanzadeh C; Guzelian J; Chrisinger JSA; Michalski JM; Oppelt P; Baumann BC
Front Oncol; 2019; 9():922. PubMed ID: 31616634
[No Abstract] [Full Text] [Related]
31. Accelerated or conventional whole brain irradiation of malignant melanoma.
Hultborn R; Sand J; Kinhult S; Lundgren L; Stierner U; Turesson I; Albertsson P
Acta Oncol; 2017 Jul; 56(7):1021-1023. PubMed ID: 28075181
[No Abstract] [Full Text] [Related]
32. [Influence of radiation on the blood-brain barrier and optimum time of chemotherapy].
Qin D; Zheng R; Ma J; Xiao J; Tang Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):307-10. PubMed ID: 12567456
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
34. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
[TBL] [Abstract][Full Text] [Related]
35. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases.
Ellerhorst J; Strom E; Nardone E; McCutcheon I
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):93-7. PubMed ID: 11163501
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.
Fan TM; Selting KA
Front Oncol; 2018; 8():680. PubMed ID: 30697532
[TBL] [Abstract][Full Text] [Related]
37. [Abscopal effect in the treatment of malignant melanoma].
Thallinger C; Prager G; Ringl H; Zielinski C
Hautarzt; 2015 Jul; 66(7):545-8. PubMed ID: 25576145
[TBL] [Abstract][Full Text] [Related]
38. Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model.
Wang P; Wu Y; Chen W; Zhang M; Qin J
Biosensors (Basel); 2022 Jan; 12(2):. PubMed ID: 35200349
[TBL] [Abstract][Full Text] [Related]
39. Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy.
Gabani P; Robinson CG; Ansstas G; Johanns TM; Huang J
Radiother Oncol; 2018 May; 127(2):310-317. PubMed ID: 29534829
[TBL] [Abstract][Full Text] [Related]
40. Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
Levy A; Chargari C; Marabelle A; Perfettini JL; Magné N; Deutsch E
Eur J Cancer; 2016 Jul; 62():36-45. PubMed ID: 27200491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
